Advanced Tools for Metabolic Health, Powered by SiPore®
Fifteen years of Swedish research and five clinical trials have led to SiPore®, a patented non-systemic silica technology that slows the breakdown of carbohydrates and fats by temporarily entrapping digestive enzymes. This produces smoother post-meal glucose curves, increased fullness, steadier appetite, and improved metabolic outcomes — all while staying entirely in the gut and exiting naturally.
Why Clinicians Adopt SIGRID
Non-systemic mechanism
Remains in the gut, never enters bloodstream, and exits naturally.
Flexible integration
Compatible with GLP-1 medications, lifestyle changes, nutritional plans, and structured weight-loss programs.
Fast clinical relevance
Effects are meal-specific and observable through CGM, glucose logs, hunger assessments, and body-composition changes.
Early Access: Join SIGRID's HCP Program Before It Opens
Be among the first clinicians in the United States to access SIGRID's new practitioner platform and clinical-grade metabolic tools. Early access is limited and prioritised for providers who register now.
What early access includes
-
Priority onboarding in January
Get entry to our HCP platform as soon as it launches, before general availability.
-
Direct access to our clinical team
A SIGRID representative can reach out now to help you evaluate fit, discuss protocols, and support your first patient use cases.
-
Practitioner-only pricing & wholesale options
Reserved for clinics, weight-management programs, metabolic health providers, and GLP-1 prescribers.
-
Clinical protocols + patient materials
Receive structured programs for weight loss, A1C reduction, GLP-1 tapering, menopause, PCOS, and longevity. Includes usage guidance, dosing frameworks, and patient handouts.
-
First access to new products
Including the professional versions of Carb Fence (Medical Food Dose) and Glucose Stabiliser (Supplement Dose).
